Consolidated Condensed Balance Sheets (Unaudited) - USD ($) $ in Millions	Jul. 31, 2024	Oct. 31, 2023
Current assets:
Cash, cash equivalents and restricted cash	$ 2,878	$ 3,232
Accounts receivable, net of allowance for credit losses of $83 and $93, respectively	4,659	4,237
Inventory	7,790	6,862
Other current assets	3,988	3,646
Total current assets	19,315	17,977
Property, plant and equipment, net	2,831	2,827
Goodwill	8,606	8,591
Other non-current assets	7,307	7,609
Total assets	38,059	37,004
Current liabilities:
Notes payable and short-term borrowings	1,396	230
Accounts payable	15,447	14,046
Other current liabilities	10,200	10,212
Total current liabilities	27,043	24,488
Long-term debt	8,229	9,254
Other non-current liabilities	4,179	4,331
Stockholders’ deficit:
Preferred stock, $0.01 par value (300 shares authorized; none issued)	0	0
Common stock, $0.01 par value (9,600 shares authorized; 963 and 989 shares issued and outstanding at July 31, 2024 and October 31, 2023, respectively)	10	10
Additional paid-in capital	1,742	1,505
Accumulated deficit	(2,729)	(2,361)
Accumulated other comprehensive loss	(415)	(223)
Total stockholders’ deficit	(1,392)	(1,069)
Total liabilities and stockholders’ deficit	$ 38,059	$ 37,004